Dover Advisors, LLC Bristol Myers Squibb CO Transaction History

Dover Advisors, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 29, 2024	BUY	$47.98 - $54.4 $231,647 - $262,643	4,828 New	4,828 $262 Million
Q1 2023 May 02, 2023	BUY	$65.71 - $74.53 $11,499 - $13,042	175 Added 6.18%	3,005 $208 Million
Q4 2022 Feb 14, 2023	BUY	$68.48 - $81.09 $193,798 - $229,484	2,830 New	2,830 $204 Million

2,407

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $115B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Dover Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Dover Advisors, LLC with notifications on news.